NEW YORK, July 19 (GenomeWeb News) - GE Healthcare will be the global distributor for Gene Logic's Sciantis online gene expression-analysis system, Gene Logic said today.
News of the deal caused shares in Gene Logic to climb 7.7 percent, or $.28, to $3.96 in heavy mid-afternoon trading today.The stock briefly reached $4.21 in late-morning trade but leveled off soon after.
Under the terms of the agreement, GE Healthcare will distribute Sciantis in 32 countries, and will be the exclusive distributor in Japan.
Financial terms of the deal were not disclosed.
Gene Logic said that Sciantis was developed for use by researchers in academia, government, and research organizations. The browser-based gene-expression application, based on Gene Logic's gene-expression reference database, enables researchers to profile the expression of more than 6,000 human, rat, and mouse genes in normal and diseased tissue, Gene Logic said.